HFA News & Notes

HFA Observes National Hepatitis Awareness Month

HFA Observes National Hepatitis Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo [...] Read More >>

Community Pharmacists Lose Bid to Immediately Block Express Scripts-Medco Deal

By Rebecca Adams, CQ HealthBeat Associate Editor A federal judge has denied the request of a group of community [...] Read More >>

People with Bleeding Disorders and HCV

Link to Access HCV Therapy Site Friends and supporters, We should all be enormously encouraged by the increasing [...] Read More >>

Contact Info

Hemophilia Federation of America
210 7th St. SE, Suite 200B
Washington D.C., 20003
800.230.9797
202.675.6984
202.675.6983

© 2011 Hemophilia Federation of America · Board of Directors Only · BB Admin Only · Privacy & Legal

Comparative Effectiveness Research (CER) highlighted on the HFA Advocacy Page

CER has been a priority issue for the HFA.  The necessity to cut costs led Congress to address CER in the health care reform debate (although CER is not a “new” issue).  Our commitment to education and awareness prompted the need for a document that outlines a definition and summary of CER.   This document has been posted to the Advocacy Section of the HFA website.   

In addition to the CER Issue Brief, the HFA posted a statement reconfirming our position on Single Source Providers.  We will to continue to post timely position papers and issue briefs under the Advocacy Section of the website.